119th Congress of SFO will be held in Paris, France
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Ciliatech leadership comments on CE mark for novel glaucoma device
Higher Molar Dose and Its Translation into Clinical Practice
EMA grants Orphan designations to MCO-010 across 5 categories of retinal dystrophies
EURETINA industry previews: Beacon Therapeutics, Nanoscope Therapeutics and Valitor
Ashvattha Therapeutics, Clearside Biomedical, ZEISS preview EURETINA presentations
Progression rates vary in subtypes of geographic atrophy lesions